Comment on "Deterministic Sensitivity Analysis Under Ignorance"

Pharmacoeconomics. 2021 Oct;39(10):1199. doi: 10.1007/s40273-021-01086-7. Epub 2021 Sep 15.

Rick A Vreman^{1

2}, Joost W Geenen^{3

4}, Saskia Knies^{5

6}, Aukje K Mantel-Teeuwisse³, Hubert G M Leufkens³, Wim G Goettsch^{3

5}

¹ Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences (UIPS), Utrecht University, Utrecht, The Netherlands. r.a.vreman@uu.nl.
² The National Health Care Institute (ZIN), Diemen, The Netherlands. r.a.vreman@uu.nl.
³ Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences (UIPS), Utrecht University, Utrecht, The Netherlands.
⁴ Roche Nederland BV, Woerden, The Netherlands.
⁵ The National Health Care Institute (ZIN), Diemen, The Netherlands.
⁶ Erasmus School of Health Policy & Management, Erasmus University Rotterdam, Rotterdam, The Netherlands.

No abstract available

Publication types